thank you, ali, for that reporting. that does it for us today. see you back here tomorrow beginning at 10:00 a.m. you can catch our show online around the clock on youtube and other platforms. i m ana cabrera from new york. andrea mitchell picks up our coverage. right now, fright night. the fight night that biden and trump campaigns are gearing up for. their first face off at this week s debate, but the candidates are taking very different approaches to their warm ups. on today s second anniversary of the dobbs decision, abortion is front and center along with the other debate topics the biden campaign is promoting. we look at what they re promoting and the trump campaign and the impact of the landmark decision on abortion on families across america. and the second of three days of hearings in the mar-a-lago documents case critics say are completely unnecessary amid continued questions about delaying tactics and judge cannon s questionable decisions. plus, prime minis
cases, that he is guilty, that the conduct, what happened, is where i think christie is trying to hit. and we ll see if it resonates. it obviously has not thus far. i think that you have seen that the indictments have been in some strange almost perverted way a boon to trump as he has gone through. and we were sitting here yesterday and the question was would there be substantive discussion of the issues during the debate. beyond just talking about trump and the indictments. do you think because at some point bret bear sayaier says weo mayor on. do you think they talked about it enough? i think counterintuitively, the answer is no. there wasn t sufficient followup when there was a raised hand about whether you would support donald trump for the nomination if he were convicted. which is a pretty significant caveat. and here is where i think that we need to reality check this
the human genome project, which was completed 20 years ago, was essentially the sequence of mostly one person. and, of course, we don t have exactly the same dna. of course, the human genome project has been incredibly successful in understanding in general terms, the diseases that are caused by inherited disorders. what we have now is something that s much wider, called the pan genome. but the first genome was taken from, what, an american who was who had african and european ancestry? 70% was taken from an african american that had european and african ancestry, so relatively broad, but it s one person s dna and, of course, there are people from other backgrounds. now, counterintuitively,
now, counterintuitively, even though there s a lot of african dna in the standard genome, it s actually the dna that s most lacking, because there s far more diversity in africa than in any other part of the world, so there are huge differences and what we need more of is different types of dna from africa, as well as from asia and the americas and so forth. so you ve got more variation and something that more accurately represents the different populations of the world. so, the obvious use for that is help with cancer treatments, certain inherited diseases have i got that right? well, it s all genetic research. what will happen is that the medicines may not be as accurate in treating people that have been diagnosed using the standard genome to something that s
pan genome. now, counterintuitively, even though there s a lot of african in the standard genome, it is actually the dna that is most lacking, because a far more diversity in africa than in any other part of this world. so there are huge differences. what we need is more different types of dna from africa as well as from asia and the americas and so forth. so you got something more varied and some are more accurately represents a different relations of world. so the